SG11201707469WA - Substituted tricyclic heterocyclic compounds - Google Patents

Substituted tricyclic heterocyclic compounds

Info

Publication number
SG11201707469WA
SG11201707469WA SG11201707469WA SG11201707469WA SG11201707469WA SG 11201707469W A SG11201707469W A SG 11201707469WA SG 11201707469W A SG11201707469W A SG 11201707469WA SG 11201707469W A SG11201707469W A SG 11201707469WA SG 11201707469W A SG11201707469W A SG 11201707469WA
Authority
SG
Singapore
Prior art keywords
heterocyclic compounds
tricyclic heterocyclic
substituted tricyclic
substituted
compounds
Prior art date
Application number
SG11201707469WA
Other languages
English (en)
Inventor
Hai-Yun Xiao
T G Murali Dhar
Jingwu Duan
Bin Jiang
Andrew J Tebben
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of SG11201707469WA publication Critical patent/SG11201707469WA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epidemiology (AREA)
SG11201707469WA 2015-03-18 2016-03-17 Substituted tricyclic heterocyclic compounds SG11201707469WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562134769P 2015-03-18 2015-03-18
PCT/US2016/022737 WO2016149436A1 (en) 2015-03-18 2016-03-17 Substituted tricyclic heterocyclic compounds

Publications (1)

Publication Number Publication Date
SG11201707469WA true SG11201707469WA (en) 2017-10-30

Family

ID=55640932

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201707469WA SG11201707469WA (en) 2015-03-18 2016-03-17 Substituted tricyclic heterocyclic compounds

Country Status (14)

Country Link
US (1) US10189840B2 (ko)
EP (1) EP3271360B1 (ko)
JP (1) JP6793657B2 (ko)
KR (1) KR102654709B1 (ko)
CN (1) CN107635993B (ko)
AU (1) AU2016233288A1 (ko)
BR (1) BR112017019773A2 (ko)
CA (1) CA2980159A1 (ko)
EA (1) EA032315B1 (ko)
ES (1) ES2797805T3 (ko)
IL (1) IL254424A0 (ko)
MX (1) MX2017011434A (ko)
SG (1) SG11201707469WA (ko)
WO (1) WO2016149436A1 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017019605A2 (pt) 2015-03-18 2018-05-08 Bristol-Myers Squibb Company compostos heterocíclicos úteis como inibidores de tnf
AU2016233289A1 (en) 2015-03-18 2017-11-09 Bristol-Myers Squibb Company Tricyclic heterocyclic compounds useful as inhibitors of TNF
TW201710257A (zh) 2015-04-17 2017-03-16 艾伯維有限公司 Tnf信號傳遞之三環調節劑
EP3294726A1 (en) 2015-04-17 2018-03-21 AbbVie Inc. Indazolones as modulators of tnf signaling
UY36628A (es) 2015-04-17 2016-11-30 Abbvie Inc Indazolonas como moduladores de la señalización de tnf
GB201510758D0 (en) 2015-06-18 2015-08-05 Ucb Biopharma Sprl Novel TNFa structure for use in therapy
EA201890421A1 (ru) 2015-08-03 2018-07-31 Бристол-Маерс Сквибб Компани Циклические соединения, пригодные в качестве модуляторов tnf-альфа
GB201621907D0 (en) 2016-12-21 2017-02-01 Ucb Biopharma Sprl And Sanofi Antibody epitope
CN110461842A (zh) 2017-03-15 2019-11-15 Ucb生物制药私人有限公司 作为tnf活性调节剂的稠合五环咪唑衍生物

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6038397B2 (ja) * 1980-03-06 1985-08-31 エスエス製薬株式会社 チアジノイミダゾ−ル誘導体及びその製造法
AU741772B2 (en) 1997-02-25 2001-12-06 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase
WO2001030778A1 (en) * 1999-10-27 2001-05-03 Novartis Ag Thiazole and imidazo [4,5-b] pyridine compounds and their pharmaceutical use
US7601846B2 (en) 2001-06-26 2009-10-13 The Regents Of The University Of California Compounds having activity as inhibitors of apoptosis
CN1633434A (zh) 2002-01-31 2005-06-29 第一制药株式会社 咪唑并[1,2-a]吡啶衍生物
WO2004050035A2 (en) 2002-12-03 2004-06-17 Isis Pharmaceuticals, Inc. Benzimidazoles and analogs thereof as antivirals
US20050124638A1 (en) 2003-12-08 2005-06-09 Swayze Eric E. Benzimidazoles and analogs thereof as antivirals
WO2009000412A1 (en) * 2007-06-26 2008-12-31 Sanofi Aventis A regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles
FR2919610B1 (fr) * 2007-08-02 2009-10-16 Sanofi Aventis Sa Derives de n-heteroaryl-carboxamides tricycliques,leur preparation et leur application en therapeutique
WO2009045174A1 (en) 2007-10-05 2009-04-09 S*Bio Pte Ltd 2-morpholinylpurines as inhibitors of pi3k
JP2009227599A (ja) 2008-03-21 2009-10-08 Daiichi Sankyo Co Ltd イミダゾピリダジン誘導体
CN101717397B (zh) 2008-10-09 2012-11-28 中国科学院上海药物研究所 一类取代吡啶并[2',1':2,3]咪唑并[4,5-c]异喹啉酮类化合物及其合成方法和用途,以及包含该类化合物的药物组合物
US8084620B2 (en) * 2008-12-19 2011-12-27 Bristol-Myers Squibb Company Carbazole carboxamide compounds useful as kinase inhibitors
WO2010111303A2 (en) 2009-03-23 2010-09-30 Siemens Medical Solutions Usa, Inc. Imaging agents for detecting neurological disorders
US8691187B2 (en) 2009-03-23 2014-04-08 Eli Lilly And Company Imaging agents for detecting neurological disorders
WO2012148550A1 (en) 2011-02-25 2012-11-01 Myrexis, Inc. Prodrugs of therapeutic compounds
EP2527344A1 (en) 2011-05-25 2012-11-28 Almirall, S.A. Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
EP2858983B1 (en) * 2012-06-11 2018-04-18 UCB Biopharma SPRL Tnf-alpha modulating benzimidazoles
GB201212513D0 (en) 2012-07-13 2012-08-29 Ucb Pharma Sa Therapeutic agents
US9309243B2 (en) 2012-07-13 2016-04-12 Ucb Biopharma Sprl Imidazopyridine derivatives as modulators of TNF activity
GB201321746D0 (en) 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
GB201321735D0 (en) 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic Agents
GB201321738D0 (en) 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic Agents
GB201321742D0 (en) 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
CN105814022B (zh) 2013-12-09 2018-09-28 Ucb生物制药私人有限公司 作为tnf活性调节剂的稠合的二环杂芳族衍生物
GB201321739D0 (en) 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
GB201321743D0 (en) 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
CA2930499C (en) 2013-12-09 2021-11-23 Ucb Biopharma Sprl Imidazopyridine derivatives as modulators of tnf activity
GB201321741D0 (en) 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
GB201321744D0 (en) 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
GB201321745D0 (en) 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
GB201321737D0 (en) 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic Agents
RS61884B1 (sr) 2014-10-06 2021-06-30 Signal Pharm Llc Supstituisana aminopurinska jedinjenja, kompozicije koje ih sadrže i postupci za lečenje u kojima se koriste
BR112017019605A2 (pt) 2015-03-18 2018-05-08 Bristol-Myers Squibb Company compostos heterocíclicos úteis como inibidores de tnf
AU2016233289A1 (en) 2015-03-18 2017-11-09 Bristol-Myers Squibb Company Tricyclic heterocyclic compounds useful as inhibitors of TNF

Also Published As

Publication number Publication date
CN107635993B (zh) 2020-05-22
WO2016149436A1 (en) 2016-09-22
US20180111936A1 (en) 2018-04-26
JP2018508553A (ja) 2018-03-29
CN107635993A (zh) 2018-01-26
ES2797805T3 (es) 2020-12-03
EP3271360B1 (en) 2020-04-22
CA2980159A1 (en) 2016-09-22
KR20170129810A (ko) 2017-11-27
US10189840B2 (en) 2019-01-29
IL254424A0 (en) 2017-11-30
JP6793657B2 (ja) 2020-12-02
KR102654709B1 (ko) 2024-04-03
BR112017019773A2 (pt) 2018-05-15
MX2017011434A (es) 2018-01-25
AU2016233288A1 (en) 2017-11-09
EA201792034A1 (ru) 2018-03-30
EP3271360A1 (en) 2018-01-24
EA032315B1 (ru) 2019-05-31

Similar Documents

Publication Publication Date Title
ZA201807249B (en) Heterocyclic compound
HK1223100A1 (zh) 雜環化合物
IL247018A0 (en) Heterocyclic compound
IL248991A0 (en) Converted dihydroisoquinolinone compounds
IL253361B (en) A tricyclic spiro compound
IL254424A0 (en) Disubstituted heterocyclic tricyclic compounds
IL285105A (en) Heterocyclic compound
HK1251465A1 (zh) 包含三環雜環化合物的組合物
IL254320A0 (en) organic compounds
EP3693360C0 (en) HETEROCYCLIC COMPOUNDS
PL3159335T3 (pl) Nowy związek heterocykliczny
IL254890B (en) The tercyclic compound
IL249907A0 (en) Tricyclic substances containing a triazole ring
IL262448B (en) Disubstituted heterocyclic bicyclic compounds
GB201521758D0 (en) Organic compounds
GB201501824D0 (en) Organic compounds
IL266099A (en) Heterocyclic composition
HUP1700522A1 (hu) Triciklusos vegyületek